EBRA Study AMISTEM-C FR

NCT05848024 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-09-29

No results posted yet for this study

Summary

Primary objective: Evaluate femoral stem migration Secondary objective: Evaluate the performance of AMIStem H Proximal Coating at 10 years after surgery; assessment of functional recovery; radiological evaluation; reporting of complications

Scores collected:

HHS, OHS, PMA, UCLA

Conditions

  • Total Hip Arthroplasty

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Principal Investigators

  • Donatien Bocquet · Hôpital privé Arras Les Bonnettes 2 rue du docteur Forgeois 62012 Arras

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-08
Primary Completion
2027-02-28
Completion
2029-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05848024 on ClinicalTrials.gov